Guy Laurent
YOU?
Author Swipe
View article: Posttraumatic Stress Disorder Symptoms in Lymphoma Patients: A Prospective Study
Posttraumatic Stress Disorder Symptoms in Lymphoma Patients: A Prospective Study Open
The cancer experience may be marked by repeat stressors and/or traumas. The aim of our study was to assess traumatic events in a group of patients diagnosed with lymphoma and to determine which of these contribute to the development of Pos…
View article: Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France
Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France Open
Background: Lymphomas are costly diseases that suffer from a lack of detailed economic information, notably in a real-world setting. Decision-makers are increasing the search for Real-World Evidence (RWE) to assess the impact, in re…
View article: Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey
Sustained degradation of quality of life in a subgroup of lymphoma survivors: a two-year prospective survey Open
View article: Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients Open
View article: Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France
Real-world costs of illness of Hodgkin and the main B-Cell Non-Hodgkin lymphomas in France Open
Background: Lymphomas are costly diseases that suffer from a lack of detailed economic information, notably in a real-world setting. Decision-makers are increasing the search for Real-World Evidence (RWE) to assess the impact, in re…
View article: Profiling Immune Escape in Hodgkin’s and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining
Profiling Immune Escape in Hodgkin’s and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining Open
Therapeutic blockade of PD-1/PD-L1 shows promising results in Hodgkin’s lymphoma (HL) and in some diffuse large B-cell lymphoma (DLBCL) patients, but biomarkers predicting such responses are still lacking. To this end, we recently develope…
View article: DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status
DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status Open
Alteration in the DNA replication, repair or recombination processes is a highly relevant mechanism of genomic instability. Despite genomic aberrations manifested in hematologic malignancies, such a defect as a source of biomarkers has bee…
View article: Improved outcome for AML patients over the years 2000–2014
Improved outcome for AML patients over the years 2000–2014 Open
View article: A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia
A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia Open
View article: Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy
Preexposure of MCF-7 breast cancer cell line to dexamethasone alters the cytotoxic effect of paclitaxel but not 5-fluorouracil or epirubicin chemotherapy Open
In light of the finding that the response of MCF-7 cells pretreated with Dex was significantly reduced, we recommend that the function of GCs should be defined more precisely if they are to be used in conjunction with chemotherapy.
View article: Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies
Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies Open
Therapy-related acute myeloid leukemia (t-AML) is a heterogeneous entity most frequently related to breast cancer or lymphoproliferative diseases (LD). Population-based studies have reported an increased risk of t-AML after treatment of ly…
View article: Impaired functional responses in follicular lymphoma CD8<sup>+</sup>TIM-3<sup>+</sup>T lymphocytes following TCR engagement
Impaired functional responses in follicular lymphoma CD8<sup>+</sup>TIM-3<sup>+</sup>T lymphocytes following TCR engagement Open
Upregulation of T cell immunoglobulin-3 (TIM-3) has been associated with negative regulation of the immune response in chronic infection and cancer, including lymphoma. Here, we investigated the possible correlation between TIM-3 expressio…
View article: Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets
Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets Open
Macrophage migration inhibitory factor (MIF) was originally identified in 1966 by Bloom and Bennett as a pro-inflammatory cytokine involved in the inhibition of macrophage motility. Since then, studies have investigated the functional cont…
View article: Ambulatory Medical Assistance - After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy
Ambulatory Medical Assistance - After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy Open
View article: Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line
Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line Open
Glucocorticoids (GCs) are used in the treatment of cancer to induce programmed cell death in the transformed cells of the hematopoietic system and to reduce side effects. Additionally, GCs are described as an inhibitor of certain chemother…